IBDEI0UK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13799,0)
 ;;=J7325^^53^656^15^^^^1
 ;;^UTILITY(U,$J,358.3,13799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13799,1,2,0)
 ;;=2^SYNVISC INTRA-ARTICULAR per 1mg
 ;;^UTILITY(U,$J,358.3,13799,1,3,0)
 ;;=3^J7325
 ;;^UTILITY(U,$J,358.3,13800,0)
 ;;=J1100^^53^656^5^^^^1
 ;;^UTILITY(U,$J,358.3,13800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13800,1,2,0)
 ;;=2^DEXAMETHASONE SOD PHOS per 1mg
 ;;^UTILITY(U,$J,358.3,13800,1,3,0)
 ;;=3^J1100
 ;;^UTILITY(U,$J,358.3,13801,0)
 ;;=J0775^^53^656^2^^^^1
 ;;^UTILITY(U,$J,358.3,13801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13801,1,2,0)
 ;;=2^CLOSTRIDIUM HISTOLYTICUM 0.01mg
 ;;^UTILITY(U,$J,358.3,13801,1,3,0)
 ;;=3^J0775
 ;;^UTILITY(U,$J,358.3,13802,0)
 ;;=J2001^^53^656^11^^^^1
 ;;^UTILITY(U,$J,358.3,13802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13802,1,2,0)
 ;;=2^LIDOCAINE IV INF 10MG
 ;;^UTILITY(U,$J,358.3,13802,1,3,0)
 ;;=3^J2001
 ;;^UTILITY(U,$J,358.3,13803,0)
 ;;=J3301^^53^656^16^^^^1
 ;;^UTILITY(U,$J,358.3,13803,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13803,1,2,0)
 ;;=2^TRIAMCINOLONE ACETONIDE 10MG
 ;;^UTILITY(U,$J,358.3,13803,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,13804,0)
 ;;=J7326^^53^656^7^^^^1
 ;;^UTILITY(U,$J,358.3,13804,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13804,1,2,0)
 ;;=2^GEL-ONE per dose
 ;;^UTILITY(U,$J,358.3,13804,1,3,0)
 ;;=3^J7326
 ;;^UTILITY(U,$J,358.3,13805,0)
 ;;=J7327^^53^656^10^^^^1
 ;;^UTILITY(U,$J,358.3,13805,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13805,1,2,0)
 ;;=2^HYALURONAN,MONOVISC,IA INJ,PER DOSE
 ;;^UTILITY(U,$J,358.3,13805,1,3,0)
 ;;=3^J7327
 ;;^UTILITY(U,$J,358.3,13806,0)
 ;;=J7318^^53^656^9^^^^1
 ;;^UTILITY(U,$J,358.3,13806,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13806,1,2,0)
 ;;=2^HYALURONAN,DUROLANE,IA INJ,1mg
 ;;^UTILITY(U,$J,358.3,13806,1,3,0)
 ;;=3^J7318
 ;;^UTILITY(U,$J,358.3,13807,0)
 ;;=J7323^^53^656^6^^^^1
 ;;^UTILITY(U,$J,358.3,13807,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13807,1,2,0)
 ;;=2^EUFLEXXA INJ,PER DOSE
 ;;^UTILITY(U,$J,358.3,13807,1,3,0)
 ;;=3^J7323
 ;;^UTILITY(U,$J,358.3,13808,0)
 ;;=12001^^53^657^3^^^^1
 ;;^UTILITY(U,$J,358.3,13808,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13808,1,2,0)
 ;;=2^REPAIR OPN WND, EXTREM, 2.5
 ;;^UTILITY(U,$J,358.3,13808,1,3,0)
 ;;=3^12001
 ;;^UTILITY(U,$J,358.3,13809,0)
 ;;=12002^^53^657^4^^^^1
 ;;^UTILITY(U,$J,358.3,13809,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13809,1,2,0)
 ;;=2^REPAIR OPN WND, EXTREM, 2.6-7.5
 ;;^UTILITY(U,$J,358.3,13809,1,3,0)
 ;;=3^12002
 ;;^UTILITY(U,$J,358.3,13810,0)
 ;;=12004^^53^657^5^^^^1
 ;;^UTILITY(U,$J,358.3,13810,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13810,1,2,0)
 ;;=2^REPAIR OPN WND, EXTREM, 7.6-12.5
 ;;^UTILITY(U,$J,358.3,13810,1,3,0)
 ;;=3^12004
 ;;^UTILITY(U,$J,358.3,13811,0)
 ;;=12005^^53^657^1^^^^1
 ;;^UTILITY(U,$J,358.3,13811,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13811,1,2,0)
 ;;=2^REPAIR OPN WND, EXTREM 12.6-20.0
 ;;^UTILITY(U,$J,358.3,13811,1,3,0)
 ;;=3^12005
 ;;^UTILITY(U,$J,358.3,13812,0)
 ;;=12006^^53^657^2^^^^1
 ;;^UTILITY(U,$J,358.3,13812,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13812,1,2,0)
 ;;=2^REPAIR OPN WND, EXTREM 20.1-30.0
 ;;^UTILITY(U,$J,358.3,13812,1,3,0)
 ;;=3^12006
 ;;^UTILITY(U,$J,358.3,13813,0)
 ;;=99415^^53^658^1^^^^1
 ;;^UTILITY(U,$J,358.3,13813,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,13813,1,2,0)
 ;;=2^Prolonged Clinical Staff Svc,Direct Care,1st Hr
